XML 18 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Public Offering
At the Market
Common Stock
Common Stock
Public Offering
Common Stock
At the Market
Additional 
Paid-In Capital
Additional 
Paid-In Capital
Public Offering
Additional 
Paid-In Capital
At the Market
Accumulated 
Deficit
Beginning balance (in shares) at Dec. 31, 2024       49,821,915            
Beginning balance at Dec. 31, 2024 $ 191,257     $ 5     $ 493,770     $ (302,518)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock, net of offering costs (in shares)         14,907,406          
Issuance of common stock, net of offering costs   $ 188,741     $ 1     $ 188,740    
Issuance of common stock from stock option exercises (in shares)       146,907            
Issuance of common stock from stock option exercises 123           123      
Stock-based compensation 3,645           3,645      
Net loss (42,211)                 (42,211)
Ending balance (in shares) at Mar. 31, 2025       64,876,228            
Ending balance at Mar. 31, 2025 $ 341,555     $ 6     686,278     (344,729)
Beginning balance (in shares) at Dec. 31, 2025 81,536,557     81,536,557            
Beginning balance at Dec. 31, 2025 $ 646,693     $ 8     1,103,854     (457,169)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock, net of offering costs (in shares)           568,320        
Issuance of common stock, net of offering costs     $ 20,187           $ 20,187  
Issuance of common stock from stock option exercises (in shares)       350,073            
Issuance of common stock from stock option exercises 4,055           4,055      
Stock-based compensation 6,548           6,548      
Net loss $ (39,339)                 (39,339)
Ending balance (in shares) at Mar. 31, 2026 82,454,950     82,454,950            
Ending balance at Mar. 31, 2026 $ 638,144     $ 8     $ 1,134,644     $ (496,508)